Search peptides, terms, sources/
Glossary

Unlicensed Medicine

A substance intended for human medical use that does not hold a UK marketing authorisation. Under the Human Medicines Regulations 2012, supplying or marketing such a substance for use in humans, even when it is labelled “for research use only,” can bring it within the regulatory framework for medicines, and its lawful supply in the UK is generally limited to specific routes, such as an authorised clinical trial or the “specials” import scheme. Most of the peptides described on this site fall into this category in the UK.

Peptides where this matters

  • BPC-157Body Protection Compound-157

    Synthetic gastric-derived peptide studied in animal models of tissue healing. Not licensed in the UK; human evidence is one small uncontrolled study.

    Repair and regenerationHuman observationalEvidence reviewed
    LimitedNot licensed in the UK
  • TB-500Thymosin Beta-4 fragment

    Short synthetic fragment linked to thymosin beta-4. Not licensed in the UK. No human trials of TB-500 itself were found; trials of the full-length protein are not evidence for it.

    Repair and regenerationAnimal studiesEvidence reviewed
    LimitedNot licensed in the UK
  • IpamorelinIPA

    Synthetic growth hormone secretagogue studied for growth hormone release. Not licensed in the UK; human evidence is one small pharmacokinetic study.

    Growth hormone axisHuman trialsEvidence reviewed
    LimitedNot licensed in the UK
  • CJC-1295CJC-1295 with DAC

    Long-acting growth-hormone-releasing hormone analogue studied for hormone levels in healthy adults. Not licensed in the UK; human evidence is small, short trials.

    Growth hormone axisHuman trialsEvidence reviewed
    LimitedNot licensed in the UK

All glossary terms

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.